| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |